Rodman David Malcom

Chief Medical Officer

1 company

Good

Trades Analyzed

12M Win Rate

37.5%

Avg 3M Return

+1.4%

Avg 12M Return

-44.1%

Rodman David Malcom is a Chief Medical Officer at Mineralys Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 19 sells.

Estimated insider holdings value: $2.1M based on current market prices.

Holdings by Company

MLYSApr 17, 2026

Current Shares70.2K

Value$2.06M

Net Activity-730,929

Bought: 0Sold: 730.9K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 17, 2026	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	416	$31.33	$13,033.28	-0.6%	-	-
Apr 15, 2026	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	20,406	$26.89	$548,672.35	-12.3%	-	-
Apr 9, 2026	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	2,170	$27.38	$59,414.60	-2.8%	-	-
Mar 13, 2026	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	20,406	$26.61	$542,973.39	-6.1%	-	-
Jan 14, 2026	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	19,076	$32.66	$623,114.66	-14.5%	-20.3%	-
Jan 12, 2026	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	8,518	$32.56	$277,339.14	-6.4%	-19.3%	-
Jan 5, 2026	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	262,752	$35.25	$9,261,028.10	-51.6%	-20.8%	-
Oct 15, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sell	10,369	$43.01	$445,982.10	-12.7%	-24.0%	-
Sep 15, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sell	11,367	$36.00	$409,265.98	-6.4%	-0.5%	-
Aug 13, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	11,365	$12.93	$146,986.95	-10.9%	+247.4%	-